Methamphetamine Insights
Vyvanse, a long-release form of methamphetamine, presents a lower risk of addiction and psychosis compared to other methods of meth use due to its gradual dopamine release. The rapid onset and peak of dopamine associated with traditional meth use significantly heighten its addictive potential and likelihood of inducing psychotic episodes. Understanding the kinetics of dopamine release is crucial in assessing the safety and risks of stimulant medications.In this clip
From this podcast
Huberman Lab
Adderall, Stimulants & Modafinil for ADHD: Short- & Long-Term Effects | Huberman Lab Podcast
Related Questions
Is Vyvanse methamphetamine as discussed in the Huberman Lab Podcast episode "Adderall, Stimulants & Modafinil for ADHD: Short- & Long-Term Effects" and the clip "Methamphetamine Insights"?
Is Vyvanse methamphetamine as discussed in the episode Adderall, Stimulants & Modafinil for ADHD: Short- & Long-Term Effects | Huberman Lab Podcast and the clip Methamphetamine Insights?
Is Vyvanse methamphetamine as discussed in the episode Adderall, Stimulants & Modafinil for ADHD: Short- & Long-Term Effects | Huberman Lab Podcast and the clip Methamphetamine Insights?